Group Urges Specialized-Drug Imports Under New Philippines Law
This article was originally published in PharmAsia News
The head of a Philippines drugstore association is urging the government to use the new Cheaper Medicines Act to focus on importing more specialized drugs not easily found in the country. The president of the Drugstores Association of the Philippines cited less-common drugs for treating cancer, which she said should be encouraged for patients who cannot afford more-expensive treatments. The Department of Health has said such expensive drugs may be included in the new law's maximum retail price provision if competition is considered unlikely to drive down prices. (Click here for more
You may also be interested in...
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.